Both therapies are based on an engineered form of the heat shock protein gp96—a molecular warning ... candidate in the ImPACT series is HS-110; the drug is currently the focus of an exploratory ...

Dillman, University of California, San Diego CARDIAC PROTECTION: UC-San Diego’s Wolfgang Dillman, right, and coauthor Ruben Mestril speculated that flooding heart cells with heat shock proteins might ...